Over the past several decades, stroke has become a leading cause of mortality and disability worldwide and there are substantial economic costs for post-stroke care, and 13.8% of participants with hypertension have elevated-CRP levels in CHARLS (20). The gene discussed is CRP; the disease is hypertensive disorder.